BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34012597)

  • 1. Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature.
    Schumann SO; Kocher G; Minervini F
    J Thorac Dis; 2021 Apr; 13(4):2510-2523. PubMed ID: 34012597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant pleural mesothelioma: diagnosis and treatment].
    Delourme J; Dhalluin X; Cortot AB; Lafitte JJ; Scherpereel A
    Rev Pneumol Clin; 2013 Feb; 69(1):26-35. PubMed ID: 23333048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.
    Zhang W; Wu X; Wu L; Zhang W; Zhao X
    Ann Transl Med; 2015 Aug; 3(13):182. PubMed ID: 26366399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging therapies in malignant pleural mesothelioma.
    Cinausero M; Rihawi K; Cortiula F; Follador A; Fasola G; Ardizzoni A
    Crit Rev Oncol Hematol; 2019 Dec; 144():102815. PubMed ID: 31670225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapleural pneumonectomies for pleural mesothelioma.
    Faccioli E; Bellini A; Mammana M; Monaci N; Schiavon M; Rea F
    Expert Rev Respir Med; 2020 Jan; 14(1):67-79. PubMed ID: 31674841
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of malignant mesothelioma.
    Jaklitsch MT; Grondin SC; Sugarbaker DJ
    World J Surg; 2001 Feb; 25(2):210-7. PubMed ID: 11338024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery for malignant pleural mesothelioma: why, when and what?
    Lang-Lazdunski L
    Lung Cancer; 2014 May; 84(2):103-9. PubMed ID: 24602395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.
    Song KJ; Flores RM; Wolf AS
    Thorac Surg Clin; 2020 Nov; 30(4):481-487. PubMed ID: 33012435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review.
    Congedo MT; West EC; Evangelista J; Mattingly AA; Calabrese G; Sassorossi C; Nocera A; Chiappetta M; Flamini S; Abenavoli L; Margaritora S; Boccuto L; Lococo F
    J Thorac Dis; 2024 Jan; 16(1):671-687. PubMed ID: 38410609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment for malignant pleural mesothelioma: extrapleural pneumonectomy, pleurectomy/decortication or extended pleurectomy?
    Hountis P; Chounti M; Matthaios D; Romanidis K; Moraitis S
    J BUON; 2015; 20(2):376-80. PubMed ID: 26011325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma.
    Marulli G; Faccioli E; Bellini A; Mammana M; Rea F
    Expert Rev Respir Med; 2017 Aug; 11(8):649-660. PubMed ID: 28580813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for immunotherapy in malignant pleural mesothelioma?
    Tartarone A; Lerose R; Aieta M
    Med Oncol; 2018 May; 35(7):98. PubMed ID: 29845408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in treatment of mesothelioma.
    Maggioni C; Barletta G; Rijavec E; Biello F; Gualco E; Grossi F
    Expert Opin Pharmacother; 2016 Jun; 17(9):1197-205. PubMed ID: 27055148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant Pleural Mesotheliomas].
    Biancosino C; Redwan B; Krüger M; Eberlein M; Bölükbas S
    Zentralbl Chir; 2016 Sep; 141 Suppl 1():S61-73. PubMed ID: 27612329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma.
    Sterman DH; Albelda SM
    Respirology; 2005 Jun; 10(3):266-83. PubMed ID: 15955137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern Malignant Mesothelioma Manifestation.
    Razzak AN; Syed A; Procknow ER; Bequest A; Jha P
    Cureus; 2023 Mar; 15(3):e36479. PubMed ID: 37090283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.
    Schwartz RM; Lieberman-Cribbin W; Wolf A; Flores RM; Taioli E
    BMC Cancer; 2018 Nov; 18(1):1188. PubMed ID: 30497433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.